investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HPV Kaiser Permanente Northern California

Mark Schiffman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
NCI is collaborating with Kaiser Permanente Northern California (KPNC) to create a carcinogenic human papillomavirus (HPV)-positive cohort for investigating the natural history of HPV genotypes. The carcinogenicity of the 15 HPV types with carcinogenic potential varies greatly, and investigators wish to increase the already proven clinical utility of carcinogenic HPV DNA testing in women 30 and older by understanding the unique properties of individual HPV types for viral persistence and progression. Investigators at the University of Montreal are testing specimens from the cohort to look at whether new HPV infections vary in risk of cervical intraepithelial neoplasia grade 2 or worse by age.

Related projects